Panacea Biotec Limited (NSE:PANACEABIO)

Panacea Biotec Revenue

In the fiscal year ending March 31, 2026, Panacea Biotec had annual revenue of 6.57B INR with 17.45% growth. Panacea Biotec had revenue of 1.69B in the quarter ending March 31, 2026, with 27.74% growth.

• Revenue: 6.57B
• Revenue Growth: +17.45%
• P/S Ratio: 4.02
• Revenue / Employee: 3.06M
• Employees: 2,149
• Market Cap: 26.37B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	6.57B	975.76M	17.45%
Mar 31, 2025	5.59B	-740.00K	-0.01%
Mar 31, 2024	5.59B	992.22M	21.57%
Mar 31, 2023	4.60B	-2.01B	-30.44%
Mar 31, 2022	6.61B	364.27M	5.83%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 3, 2026

Data Sources Report a data error